CDK4 and hepatocellular carcinoma: Metformin causes G1 cell cycle arrest in human hepatocellular carcinoma (HCC) cells,5 while CDK4/6 inhibitors tend to inhibit the transition from G1 to S.15 We therefore evaluated cell cycle progression in treated U251 cells with flow cytometry.